Drug Search Results
More Filters [+]

Gamma-iridium-192

Alternative Names: gamma-iridium-192, gammairidium192, gamma iridium 192
Latest Update: 2008-04-24
Latest Update Note: Clinical Trial Update

Product Description

radiation source

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Cordis
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Gamma-iridium-192

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Myocardial Ischemia|Coronary Artery Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

GAMMA V

P2

Completed

Myocardial Ischemia|Coronary Artery Disease

None

Recent News Events

Date

Type

Title